DuPont de Nemours Stock (US26614N1028): Goldman Sachs starts coverage at Neutral with $53 target

Goldman Sachs has initiated coverage of DuPont de Nemours with a Neutral rating and a $53 price target, adding a fresh Wall Street view as the NYSE-listed materials group trades below the new target.

Responsible: ad hoc news Earnings Desk. Reviewed prior to publication on June 15, 2026 at 5:32 PM ET. Details in the imprint.

Goldman Sachs has initiated coverage of DuPont de Nemours with a Neutral rating and a $53 price target, adding a fresh large-bank view on the NYSE-listed specialty materials group. The initiation, highlighted in a Monday analyst call overview, comes after a period of solid share-price gains and renewed focus on DuPont's portfolio positioning in water, healthcare and advanced materials. DuPont de Nemours shares trade on the New York Stock Exchange under the ticker "DD" and remain below the new Goldman Sachs target, leaving moderate implied upside versus the latest quoted levels.

Goldman Sachs initiation: Neutral stance and $53 price target

According to an analyst summary reported on Monday, Goldman Sachs started coverage of DuPont de Nemours stock with a Neutral rating and a $53 per-share price target. The new recommendation places DuPont in the middle of Goldman Sachs' rating scale, signaling neither a clear outperform nor an underperform call at current valuation levels. The $53 target represents a modest premium to where DuPont has recently been quoted, indicating that Goldman Sachs sees some upside potential but not enough to justify a Buy rating.

The Goldman Sachs initiation joins an already active analyst community following DuPont, with MarketBeat data pointing to a broader consensus rating of Moderate Buy and an average price target above $55. In that dataset, twelve analysts rate the stock Buy, four Hold and one Sell, with an average target of about $55.07 and some price objectives extending into the high-$50s range. Against that backdrop, Goldman Sachs' $53 target sits below the existing average but still above recent trading levels, effectively positioning the new call as somewhat cautious relative to the broader Street.

Additional coverage compiled by StockAnalysis and Google Finance indicates that recent 12-month Wall Street price targets for DuPont have tended to cluster in the mid-$50s, with some estimates around $56 on average and higher individual targets up to roughly $62. Those consensus figures imply upside in the low- to mid-20 percent range from price points near the high-$40s, reinforcing that many analysts see DuPont as undervalued based on earnings and cash-flow expectations. In this context, Goldman Sachs' new $53 target appears somewhat conservative compared with the highest targets but still broadly aligned with a view that DuPont's current valuation already reflects a substantial portion of the expected improvement.

The initiation also comes after notable share-price performance over the past several quarters, with Investing.com highlighting that DuPont shares have risen about 47 percent since the company's September 2025 analyst day, compared with a 12 percent gain for the S&P 500 and 15 percent for the XLI industrial sector index over the same period. That outperformance versus both the broader market and the industrial benchmark provides part of the backdrop for a Neutral rating, as a stronger share-price run can compress the margin of safety and reduce the valuation gap to sector peers. For investors examining the stock today, the Goldman Sachs stance effectively acknowledges DuPont's operational progress and portfolio repositioning while emphasizing that a significant part of the re-rating may already be in the price.

How DuPont looks on valuation and fundamentals after the new call

Recent valuation snapshots show that DuPont de Nemours carries a market capitalization around the high-teens billion-dollar range, underscoring its role as a mid- to large-cap player in the global specialty materials space. CompaniesMarketCap data places DuPont's market cap near $19.4 billion in May and June 2026, ranking it just above the 1,200th most valuable company worldwide by that measure. That size category positions DuPont below mega-cap chemical and coatings peers but still large enough to attract coverage from major Wall Street banks such as Goldman Sachs.

While the latest detailed earnings release is not in focus for today's initiation-driven news, previous coverage has emphasized DuPont's emphasis on a more streamlined, higher-margin portfolio following divestments and spin-offs in recent years. The company has refocused on core segments in electronics, water solutions, healthcare-related materials and advanced polymers, aiming to deliver more consistent cash flow and improve its return on invested capital. These shifts are a key reason why analysts, including those referenced by MarketBeat and Investing.com, have highlighted DuPont's ability to generate incremental margin expansion over time.

Dividend data from StockAnalysis indicates that DuPont continues to return capital to shareholders through regular quarterly dividends, underscoring the stock's income component alongside potential price appreciation. As of the latest available figures, DuPont's annualized dividend stands at roughly $1.64 per share, translating into a yield slightly above 2 percent based on prior share-price levels. That payout level positions DuPont as a moderate-yield holding in the materials sector, offering a combination of income and cyclical exposure rather than a purely high-dividend profile.

Coverage from IT Boltwise and earlier ad hoc news reporting has stressed that the recent uptrend in DuPont's share price has brought the stock closer to the upper end of its recent trading range, while still leaving a gap to the mid-50s average analyst target. In those discussions, DuPont's valuation metrics, including price-to-earnings and enterprise-value-to-EBITDA multiples, have often been compared with broader chemicals and materials peers, suggesting that the stock trades at a discount to high-growth specialty names but at a premium to more cyclical commodity chemical producers. The Goldman Sachs Neutral rating fits into this narrative by implying that the current valuation is reasonably balanced against the company's growth and margin trajectory.

Analyst day commentary referenced by Investing.com points out that DuPont has been emphasizing secular demand trends in water purification, healthcare consumables and advanced materials for electronics as growth pillars. These end markets can provide relatively resilient volume demand compared with purely construction- or automotive-driven chemical businesses, which in turn has influenced how analysts build their long-term models for revenue and EBITDA. In particular, the focus on water and healthcare solutions has been cited as a potential support for margins, as those businesses often carry higher value-added content and pricing power.

At the same time, DuPont's track record of portfolio reshaping means that analysts continue to monitor execution risk, especially around integration, cost savings and potential further divestitures or bolt-on acquisitions. Market participants following the stock frequently debate the balance between portfolio optimization and the need to drive organic growth, an issue that can influence whether a rating leans toward Buy or Hold. Against that backdrop, a Neutral stance by Goldman Sachs suggests a more cautious approach to these moving parts, particularly after a near-50 percent share-price run since late 2025.

Where DuPont stands among Wall Street views and sector peers

The Goldman Sachs initiation adds to an existing list of major banks and brokers that already cover DuPont with a broad range of opinions. MarketBeat's compilation showing a Moderate Buy consensus rating, with twelve Buys, four Holds and one Sell, illustrates that most analysts are constructive but not unanimously bullish on the name. The spread of targets from the low-$50s to the low-$60s further confirms that there is debate around how much valuation upside remains after the recent share-price rally.

From a sector standpoint, DuPont is often grouped with diversified materials and specialty chemical companies rather than pure-play commodity producers. While individual peers can vary depending on the specific product line being analyzed, investors commonly compare DuPont's capital returns, margins and growth profile with those of other US-listed materials names tracked in industrial and materials sector indices such as the S&P 500 and XLI. In that peer context, DuPont has sought to position itself as a more focused, higher-margin player, a narrative that underpins many of the Buy ratings and the average target above $55.

The note summarizing Goldman Sachs' call on Investing.com mentions that DuPont's share-price performance since the September 2025 analyst day has exceeded both the S&P 500 and the industrials sector index, a factor that often encourages more neutral ratings as valuation multiples expand. Analyst models typically incorporate this outperformance by adjusting forward multiples nearer to historical midpoints or sector averages, which can cap upside in target prices unless earnings expectations move higher. In DuPont's case, the new $53 target roughly aligns with this more normalized-multiple approach, leaving some room for upside if operational improvements stay on track.

Earlier coverage by IT Boltwise highlighted that DuPont's valuation remained below the mid-range implied by consensus price targets, even after several trading sessions of gains that pushed the stock toward the upper end of its recent band. That gap between market price and consensus target has drawn attention among valuation-focused investors, particularly as DuPont's restructured portfolio begins to show more stable margins and cash generation. The Goldman Sachs Neutral call may reduce some of that valuation tension by anchoring a prominent new target slightly below the broader average, though still comfortably above the current quote.

For investors following analyst actions, Monday's initiation also features DuPont alongside several other large-cap names that received new ratings or target adjustments, as detailed in a Wall Street research call roundup. In that list, DuPont's Neutral rating contrasts with Buy initiations or upgrades in other sectors, reinforcing that Goldman Sachs sees DuPont as more of a balanced risk-reward story rather than a high-conviction outperform idea at this time. Such positioning can influence how portfolio managers allocate capital within the materials sleeve of diversified US equity portfolios, particularly those that use major bank research as an input into their processes.

Overall, the combination of a Neutral rating, a $53 target and a share price that has already outperformed key benchmarks suggests that Goldman Sachs views DuPont as fairly valued to slightly undervalued, with execution on its portfolio and margin strategy as the key driver for any further re-rating. Investors watching the stock may therefore focus on upcoming quarterly earnings, capital-allocation decisions and any additional portfolio moves to assess whether DuPont can close the gap to the higher end of analyst targets or whether the recent outperformance has largely run its course.

DuPont de Nemours at a glance

• Name: DuPont de Nemours, Inc.
• Industry: Specialty chemicals and advanced materials
• Headquarters: Wilmington, Delaware, United States
• Core markets: Electronics, water solutions, healthcare materials and advanced polymers
• Revenue drivers: High-performance materials, filtration and purification solutions, and applications for electronics and healthcare end markets
• Listing: New York Stock Exchange, ticker DD; commonly followed as part of major US materials and industrial indices
• Trading currency: US dollars (USD)

This article was created with a.i. assistance and editorially reviewed. Not investment advice, not a buy or sell recommendation. Trading in securities carries risks up to the total loss of capital.